HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 540/3/791    most recent 2002.016394v1 Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, G. Articles by Lemos, J. R. Search for Related Content PubMed PubMed Citation Articles by Wang, G. Articles by Lemos, J. R.

Adenosine inhibition via A₁ receptor of N-type Ca²⁺ current and peptide release from isolated neurohypophysial terminals of the rat

Gang Wang *†, Govindan Dayanithi ‡, Edward E. Custer * and José R. Lemos *

Effects of adenosine on voltage-gated Ca²⁺ channel currents and on arginine vasopressin (AVP) and oxytocin (OT) release from isolated neurohypophysial (NH) terminals of the rat were investigated using perforated-patch clamp recordings and hormone-specific radioimmunoassays. Adenosine, but not adenosine 5'-triphosphate (ATP), dose-dependently and reversibly inhibited the transient component of the whole-terminal Ba²⁺ currents, with an IC₅₀ of 0.875 µM. Adenosine strongly inhibited, in a dose-dependent manner (IC₅₀ = 2.67 µM), depolarization-triggered AVP and OT release from isolated NH terminals. Adenosine and the N-type Ca²⁺ channel blocker -conotoxin GVIA, but not other Ca²⁺ channel-type antagonists, inhibited the same transient component of the Ba²⁺ current. Other components such as the L-, Q- and R-type channels, however, were insensitive to adenosine. Similarly, only adenosine and -conotoxin GVIA were able to inhibit the same component of AVP release. A₁ receptor agonists, but not other purinoceptor-type agonists, inhibited the same transient component of the Ba²⁺ current as adenosine. Furthermore, the A₁ receptor antagonist 8-cyclopentyltheophylline (CPT), but not the A₂ receptor antagonist 3, 7-dimethyl-1-propargylxanthine (DMPGX), reversed inhibition of this current component by adenosine. The inhibition of AVP and OT release also appeared to be via the A₁ receptor, since it was reversed by CPT. We therefore conclude that adenosine, acting via A₁ receptors, specifically blocks the terminal N-type Ca²⁺ channel thus leading to inhibition of the release of both AVP and OT.

This article has been cited by other articles:

				G. Burnstock Physiology and Pathophysiology of Purinergic Neurotransmission Physiol Rev, April 1, 2007; 87(2): 659 - 797. [Abstract] [Full Text] [PDF]

				T. B. Brust, F. S. Cayabyab, N. Zhou, and B. A. MacVicar p38 Mitogen-Activated Protein Kinase Contributes to Adenosine A1 Receptor-Mediated Synaptic Depression in Area CA1 of the Rat Hippocampus J. Neurosci., November 29, 2006; 26(48): 12427 - 12438. [Abstract] [Full Text] [PDF]

				P. M. Bull, C. H. Brown, J. A. Russell, and M. Ludwig Activity-dependent feedback modulation of spike patterning of supraoptic nucleus neurons by endogenous adenosine Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R83 - R90. [Abstract] [Full Text] [PDF]

				T. A. Ponzio and G. I. Hatton Adenosine Postsynaptically Modulates Supraoptic Neuronal Excitability J Neurophysiol, January 1, 2005; 93(1): 535 - 547. [Abstract] [Full Text] [PDF]

				G. Wang, J. Anrather, J. Huang, R. C. Speth, V. M. Pickel, and C. Iadecola NADPH Oxidase Contributes to Angiotensin II Signaling in the Nucleus Tractus Solitarius J. Neurosci., June 16, 2004; 24(24): 5516 - 5524. [Abstract] [Full Text] [PDF]